Equities

Hangzhou AGS MedTech Co Ltd

688581:SHH

Hangzhou AGS MedTech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)61.21
  • Today's Change-0.79 / -1.27%
  • Shares traded901.67k
  • 1 Year change-24.23%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,037267204
Total Receivables, Net602115
Total Inventory473940
Prepaid expenses2.213.922.48
Other current assets, total0.011.521.28
Total current assets2,146332263
Property, plant & equipment, net16211856
Goodwill, net------
Intangibles, net192020
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets2,331473342
LIABILITIES
Accounts payable513532
Accrued expenses35249.41
Notes payable/short-term debt125.656.62
Current portion long-term debt/capital leases0.571.080.94
Other current liabilities, total222520
Total current liabilities1219169
Total long term debt00.571.39
Total debt137.298.95
Deferred income tax----0.16
Minority interest------
Other liabilities, total2.10----
Total liabilities1239271
SHAREHOLDERS EQUITY
Common stock584343
Additional paid-in capital1,7157777
Retained earnings (accumulated deficit)435262152
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.110.07(0.1)
Total equity2,208382271
Total liabilities & shareholders' equity2,331473342
Total common shares outstanding818181
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.